Risankizumab

Rarity: Common

The most frequent rarity: most Wikipedia articles become Commons.

Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.

At a glance

Class

Notion

Domain

Science and technology

In collections

Nobody has pulled it yet.

What Wikipedia says

Risankizumab ( RIS-ən-KIZ-uu-mab), sold under the brand name Skyrizi ( sky-RIZZ-ee), is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. It is designed to target interleukin 23A (IL-23A). It is given by subcutaneous injection.

Excerpt from the Wikipedia article “Risankizumab”, under the CC BY-SA 4.0 license. Read the article on Wikipedia